OKYO Pharma Limited
OKYO · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $50 | $43 | $37 | $55 |
| - Cash | $2 | $1 | $4 | $3 |
| + Debt | $0 | $0 | $2 | $0 |
| Enterprise Value | $49 | $42 | $36 | $52 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$16 | -$13 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$17 | -$13 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.12 | -0.001 | -0.6 | -0.36 |
| % Growth | -19,900% | 99.9% | -66.7% | – |
| Operating Cash Flow | -$2 | -$9 | -$8 | -$5 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$2 | -$9 | -$8 | -$5 |